000			01932 a2200541 4500
005			20250515052348.0
264		0	_c20070423
008			200704s 0 0 eng d
022			_a0009-9236
024	7		_a10.1038/sj.clpt.6100038 _2doi
040			_aNLM _beng _cNLM
100	1		_aLau, Y Y
245	0	0	_aeffect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. _h[electronic resource]
260			_bClinical pharmacology and therapeutics _cFeb 2007
300			_a194-204 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aArea Under Curve
650	0	4	_aAtorvastatin
650	0	4	_aBile _xchemistry
650	0	4	_aBinding, Competitive
650	0	4	_aBiological Transport _xdrug effects
650	0	4	_aCell Line
650	0	4	_aCross-Over Studies
650	0	4	_aEnzyme Inhibitors _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHeptanoic Acids _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage
650	0	4	_aInfusions, Intravenous
650	0	4	_aLiver _xdrug effects
650	0	4	_aLiver-Specific Organic Anion Transporter 1
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrganic Anion Transporters _xantagonists & inhibitors
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aSubstrate Specificity
650	0	4	_aTablets
650	0	4	_aTransfection
700	1		_aHuang, Y
700	1		_aFrassetto, L
700	1		_aBenet, L Z
773	0		_tClinical pharmacology and therapeutics _gvol. 81 _gno. 2 _gp. 194-204
856	4	0	_uhttps://doi.org/10.1038/sj.clpt.6100038 _zAvailable from publisher's website
999			_c16759867 _d16759867